Organogenesis Holdings (ORGO) Short term Debt (2017 - 2024)

Organogenesis Holdings' Short term Debt history runs 8 years deep, the most recent figure standing at $6.0 million for Q3 2024.

• On a quarterly basis, Short term Debt rose 8.77% year-over-year to $6.0 million in Q3 2024; TTM through Sep 2024 was $6.0 million, a 8.77% increase from a year earlier, with the FY2023 full-year figure at $5.5 million, up 20.89% from the prior year.
• Short term Debt climbed to $6.0 million in Q3 2024 per ORGO's latest filing, from $5.8 million in the prior quarter.
• Across five years, Short term Debt topped out at $22.5 million in Q2 2021 and bottomed at $1.7 million in Q1 2020.
• The 5-year median for Short term Debt is $5.5 million (2023), against an average of $7.1 million.
• Biggest YoY gain for Short term Debt was 912.3% in 2021; the steepest drop was 84.06% in 2021.
• Year by year, Short term Debt stood at $16.7 million in 2020, then plunged by 84.06% to $2.7 million in 2021, then jumped by 70.86% to $4.5 million in 2022, then gained by 20.89% to $5.5 million in 2023, then rose by 8.71% to $6.0 million in 2024.
• Per Business Quant, the three latest ORGO Short term Debt figures stand at $6.0 million (Q3 2024), $5.8 million (Q2 2024), and $5.5 million (Q1 2024).